Gilead Layoffscareer Detail - Top Viral
Gilead Sciences, a biopharma company, achieves bold ambitions to help make the world a healthier place, leading in HIV, liver disease, cancer & inflammation. FOSTER CITY, Calif. & MUNICH-- (BUSINESS WIRE)-- Gilead Sciences, Inc.
Understanding the Context
(Nasdaq: GILD) today announced it has entered into a definitive agreement to acquire Tubulis GmbH, a private Germany-based, clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs), building on Gilead’s oncology pipeline, focused on addressing areas of high unmet need. The ... Learn about the biopharmaceutical company Gilead Sciences, including mission, vision, values, history, impact, leadership, therapeutic areas and other information. Gilead, a global biopharma co.
Image Gallery
Key Insights
pursuing innovation in virology, oncology and inflammation, offers a variety of career opportunities in an inclusive workplace where all can make an impact. – Acquisition Adds TUB-040, a NaPi2b Targeting ADC for Ovarian Cancer and other Solid Tumors, to Gilead Pipeline – – Industry Leading ADC Platform That Includes its Clinically-Validated Tubutecan Linker-Payload Technology and Next-Generation Platform to Expand Gilead’s ADC Capabilities – Gilead Sciences, Inc. (Nasdaq: GILD) today announced it has entered into a definitive agreement ... Gilead is committed to helping improve the lives of people around the world by bringing forward medicines that prevent, treat and cure devastating diseases. Through science and innovative partnerships, Gilead expands research and development programs in virology, oncology, & inflammation.
Related Articles You Might Like:
Your Go To Destination For Plus Size Style Lane Bryant Johnson Creek Wi Kwik Trip Bacon Wrapped Pork Filet In Air Fryercompany Landing Fedex Office Fedex Office Print Ship CenterFinal Thoughts
Learn about our pipeline. Gilead Sciences advances world-class research that generates transformative medicines to address critical needs across virology, oncology & inflammation.